A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Successful Treatment of Vancomycin-Intermediate Staphylococcus aureus Pacemaker Lead Infective Endocarditis with Telavancin

(2010) L. A. Marcos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Antimicrobial Stewardship Program’s Impact with Rapid Polymerase Chain Reaction Methicillin‐ResistantStaphylococcus aureus/S. aureusBlood Culture Test in Patients withS. aureusBacteremia

(2010) Karri A. Bauer et al.   CLINICAL INFECTIOUS DISEASES

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin

(2010) H. Nace et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia

(2010) S. S. Hegde et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

(2009) C. S. Lunde et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients

(2009) Y. Li et al.   Clinical Journal of the American Society of Nephrology

Vancomycin Heteroresistance and Methicillin-ResistantStaphylococcus aureus

(2009) Stan Deresinski   JOURNAL OF INFECTIOUS DISEASES

Vancomycin-Resistant Staphylococcus aureus: A Perfect but Geographically Limited Storm?

(2008) F. C. Tenover   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES